Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/9664
Title: Moving towards a strategy to accelerate cervical cancer elimination in a high-burden city - Lessons learned from the Amazon city of Manaus, Brazil.
Authors: Torres, Ka´tia Luz
Rondon, Heidy Halanna de Melo Farah
Martins, Toni Ricardo
Martins, Sandro José
Ribeiro, Ana
Alencar, Tainá Raiol
Marques, Carla Pintas
Corrêa, Flávia de Miranda
Santos, Arn Migowski Rocha dos
Schiffman, Mark
Rodriguez, Ana Cecilia
Gage, Julia C.
Minuzzi, Thaís Tâmara Castro e Souza
Keywords: Neoplasias do Colo do Útero
Uterine Cervical Neoplasms
Neoplasias del Cuello Uterino
Vacinas contra Papillomavirus
Papillomavirus Vaccines
Vacunas contra Papillomavirus
Detecção Precoce de Câncer
Early Detection of Cancer
Detección Precoz del Cáncer
Issue Date: 2021
Publisher: Plos one
Citation: TORRES, Kátia Luz; RONDON, Heidy Halanna de Melo Farah; MARTINS , Toni Ricardo; MARTINS, Sandro José; RIBEIRO, Ana; ALENCAR, Tainá Raiol; MARQUES , Carla Pintas; CORRÊA , Flávia de Miranda; SANTOS , Arn Migowski Rocha dos; MINUZZI-SOUZA , Thais Taˆmara Castro e; SCHIFFMAN, Mark; RODRIGUEZ , Ana Cecilia; GAGE , Julia C. Moving towards a strategy to accelerate cervical cancer elimination in a high-burden city - Lessons learned from the Amazon city of Manaus, Brazil. Plos one, Estados Unidos, v. 16, n. 10, 2021. DOI https://doi.org/10.1371/journal. pone.0258539.
Abstract: The World Health Organization Call to Eliminate Cervical Cancer resonates in cities like Manaus, Brazil, where the burden is among the world’s highest. Manaus has offered free cytology-based screening since 1990 and HPV immunization since 2013, but the public system is constrained by many challenges and performance is not well-defined. We obtained cervical cancer prevention activities within Manaus public health records for 2019 to evaluate immunization and screening coverage, screening by region and neighborhood, and the annual Pink October screening campaign. We estimated that among girls and boys age 14–18, 85.9% and 64.9% had 1+ doses of HPV vaccine, higher than rates for age 9–13 (73.4% and 43.3%, respectively). Of the 90,209 cytology tests performed, 24.9% were outside the target age and the remaining 72,230 corresponded to 40.1% of the target population (one-third of women age 25–64). The East zone had highest screening coverage (49.1%), highest high-grade cytology rate (2.5%) and lowest estimated cancers (38.1/100,000) compared with the South zone (32.9%, 1.8% and 48.5/100,000, respectively). Largest neighborhoods had fewer per capita screening locations, resulting in lower coverage. During October, some clinics successfully achieved higher screening volumes and high-grade cytology rates (up to 15.4%). Although we found evidence of some follow-up within 10 months post-screening for 51/70 women (72.9%) with high-grade or worse cytology, only 18 had complete work-up confirmed. Manaus has successfully initiated HPV vaccination, forecasting substantial cervical cancer reductions by 2050. With concerted efforts during campaigns, some clinics improved screening coverage and reached high-risk women. Screening campaigns in community locations in high-risk neighborhoods using self-collected HPV testing can achieve widespread coverage. Simplifying triage and treatment with fewer visits closer to communities would greatly improve follow-up and program effectiveness. Achieving WHO Cervical Cancer Elimination goals in high-burden cities will require major reforms for screening and simpler follow-up and treatment.
Description: v. 16, n. 10, 2021
URI: http://sr-vmlxaph03:8080/jspui/handle/123456789/9664
ISSN: 1932-6203
Appears in Collections:Artigos de Periódicos da área de Detecção Precoce



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.